Q1 EPS Forecast for Bath & Body Works Increased by Analyst

Bath & Body Works, Inc. (NYSE:BBWIFree Report) – Telsey Advisory Group upped their Q1 2026 earnings estimates for Bath & Body Works in a research report issued on Tuesday, May 20th. Telsey Advisory Group analyst D. Telsey now forecasts that the company will post earnings of $0.49 per share for the quarter, up from their prior forecast of $0.42. Telsey Advisory Group has a “Outperform” rating and a $43.00 price objective on the stock. The consensus estimate for Bath & Body Works’ current full-year earnings is $3.30 per share. Telsey Advisory Group also issued estimates for Bath & Body Works’ Q4 2026 earnings at $2.21 EPS and FY2026 earnings at $3.60 EPS.

A number of other equities analysts have also issued reports on BBWI. Robert W. Baird boosted their target price on shares of Bath & Body Works from $45.00 to $47.00 and gave the stock an “outperform” rating in a research report on Friday, February 28th. Morgan Stanley dropped their target price on shares of Bath & Body Works from $49.00 to $43.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 6th. Wells Fargo & Company boosted their target price on shares of Bath & Body Works from $40.00 to $44.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 14th. Raymond James dropped their target price on shares of Bath & Body Works from $46.00 to $37.00 and set an “outperform” rating on the stock in a research report on Thursday, April 17th. Finally, Barclays boosted their target price on shares of Bath & Body Works from $31.00 to $35.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Four equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, Bath & Body Works has a consensus rating of “Moderate Buy” and a consensus price target of $42.56.

View Our Latest Analysis on BBWI

Bath & Body Works Trading Up 0.6%

Shares of Bath & Body Works stock opened at $31.36 on Thursday. The firm has a fifty day simple moving average of $30.21 and a 200-day simple moving average of $34.01. Bath & Body Works has a 1-year low of $24.96 and a 1-year high of $52.99. The stock has a market capitalization of $6.68 billion, a price-to-earnings ratio of 7.65, a PEG ratio of 0.92 and a beta of 1.87.

Bath & Body Works (NYSE:BBWIGet Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $2.79 billion during the quarter, compared to analysts’ expectations of $2.78 billion.

Institutional Investors Weigh In On Bath & Body Works

Several large investors have recently made changes to their positions in BBWI. Park Avenue Securities LLC bought a new stake in shares of Bath & Body Works in the 4th quarter worth about $270,000. UMB Bank n.a. grew its holdings in shares of Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after purchasing an additional 335 shares during the last quarter. Missouri Trust & Investment Co grew its holdings in shares of Bath & Body Works by 7.2% in the 4th quarter. Missouri Trust & Investment Co now owns 39,570 shares of the company’s stock worth $1,534,000 after purchasing an additional 2,660 shares during the last quarter. Janney Montgomery Scott LLC bought a new stake in shares of Bath & Body Works in the 4th quarter worth about $372,000. Finally, Avior Wealth Management LLC grew its holdings in Bath & Body Works by 30.3% during the 4th quarter. Avior Wealth Management LLC now owns 1,950 shares of the company’s stock worth $76,000 after acquiring an additional 453 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works announced that its Board of Directors has approved a share repurchase program on Thursday, February 27th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 6.4% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s leadership believes its shares are undervalued.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.55%. The ex-dividend date is Friday, June 6th. Bath & Body Works’s payout ratio is 21.98%.

About Bath & Body Works

(Get Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Further Reading

Earnings History and Estimates for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.